001     137436
005     20240321220240.0
024 7 _ |a 10.1136/jmedgenet-2013-102200
|2 doi
024 7 _ |a pmid:24780882
|2 pmid
024 7 _ |a pmc:PMC4078703
|2 pmc
024 7 _ |a 0022-2593
|2 ISSN
024 7 _ |a 1468-6244
|2 ISSN
024 7 _ |a altmetric:2313466
|2 altmetric
037 _ _ |a DZNE-2020-03758
041 _ _ |a English
082 _ _ |a 610
100 1 _ |a Tezenas du Montcel, Sophie
|0 P:(DE-HGF)0
|b 0
|e Corresponding author
245 _ _ |a Prediction of the age at onset in spinocerebellar ataxia type 1, 2, 3 and 6.
260 _ _ |a London
|c 2014
|b BMJ Publishing Group
264 _ 1 |3 online
|2 Crossref
|b BMJ
|c 2014-04-29
264 _ 1 |3 print
|2 Crossref
|b BMJ
|c 2014-07-01
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1585215238_28192
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
520 _ _ |a The most common spinocerebellar ataxias (SCA)--SCA1, SCA2, SCA3, and SCA6--are caused by (CAG)n repeat expansion. While the number of repeats of the coding (CAG)n expansions is correlated with the age at onset, there are no appropriate models that include both affected and preclinical carriers allowing for the prediction of age at onset.We combined data from two major European cohorts of SCA1, SCA2, SCA3, and SCA6 mutation carriers: 1187 affected individuals from the EUROSCA registry and 123 preclinical individuals from the RISCA cohort. For each SCA genotype, a regression model was fitted using a log-normal distribution for age at onset with the repeat length of the alleles as covariates. From these models, we calculated expected age at onset from birth and conditionally that this age is greater than the current age.For SCA2 and SCA3 genotypes, the expanded allele was a significant predictor of age at onset (-0.105±0.005 and -0.056±0.003) while for SCA1 and SCA6 genotypes both the size of the expanded and normal alleles were significant (expanded: -0.049±0.002 and -0.090±0.009, respectively; normal: +0.013±0.005 and -0.029±0.010, respectively). According to the model, we indicated the median values (90% critical region) and the expectancy (SD) of the predicted age at onset for each SCA genotype according to the CAG repeat size and current age.These estimations can be valuable in clinical and research. However, results need to be confirmed in other independent cohorts and in future longitudinal studies.NCT01037777 and NCT00136630 for the French patients.
536 _ _ |a 344 - Clinical and Health Care Research (POF3-344)
|0 G:(DE-HGF)POF3-344
|c POF3-344
|f POF III
|x 0
536 _ _ |a 345 - Population Studies and Genetics (POF3-345)
|0 G:(DE-HGF)POF3-345
|c POF3-345
|f POF III
|x 1
588 _ _ |a Dataset connected to CrossRef, PubMed,
650 _ 2 |a Adult
|2 MeSH
650 _ 2 |a Age of Onset
|2 MeSH
650 _ 2 |a Algorithms
|2 MeSH
650 _ 2 |a Female
|2 MeSH
650 _ 2 |a Genotype
|2 MeSH
650 _ 2 |a Humans
|2 MeSH
650 _ 2 |a Male
|2 MeSH
650 _ 2 |a Middle Aged
|2 MeSH
650 _ 2 |a Models, Genetic
|2 MeSH
650 _ 2 |a Models, Statistical
|2 MeSH
650 _ 2 |a Spinocerebellar Ataxias: epidemiology
|2 MeSH
650 _ 2 |a Spinocerebellar Ataxias: genetics
|2 MeSH
700 1 _ |a Durr, Alexandra
|0 P:(DE-HGF)0
|b 1
700 1 _ |a Rakowicz, Maria
|0 P:(DE-HGF)0
|b 2
700 1 _ |a Nanetti, Lorenzo
|0 P:(DE-HGF)0
|b 3
700 1 _ |a Charles, Perrine
|0 P:(DE-HGF)0
|b 4
700 1 _ |a Sulek, Anna
|0 P:(DE-HGF)0
|b 5
700 1 _ |a Mariotti, Caterina
|0 P:(DE-HGF)0
|b 6
700 1 _ |a Rola, Rafal
|0 P:(DE-HGF)0
|b 7
700 1 _ |a Schols, Ludger
|0 P:(DE-2719)2810795
|b 8
|u dzne
700 1 _ |a Bauer, Peter
|0 P:(DE-HGF)0
|b 9
700 1 _ |a Dufaure-Garé, Isabelle
|0 P:(DE-HGF)0
|b 10
700 1 _ |a Jacobi, Heike
|0 P:(DE-HGF)0
|b 11
700 1 _ |a Forlani, Sylvie
|0 P:(DE-HGF)0
|b 12
700 1 _ |a Schmitz-Hübsch, Tanja
|0 P:(DE-HGF)0
|b 13
700 1 _ |a Filla, Alessandro
|0 P:(DE-HGF)0
|b 14
700 1 _ |a Timmann, Dagmar
|0 P:(DE-HGF)0
|b 15
700 1 _ |a van de Warrenburg, Bart P
|0 P:(DE-HGF)0
|b 16
700 1 _ |a Marelli, Cecila
|0 P:(DE-HGF)0
|b 17
700 1 _ |a Kang, Jun-Suk
|0 P:(DE-HGF)0
|b 18
700 1 _ |a Giunti, Paola
|0 P:(DE-HGF)0
|b 19
700 1 _ |a Cook, Arron
|0 P:(DE-HGF)0
|b 20
700 1 _ |a Baliko, Laszlo
|0 P:(DE-HGF)0
|b 21
700 1 _ |a Melegh, Béla
|0 P:(DE-HGF)0
|b 22
700 1 _ |a Bela, Melegh
|0 P:(DE-HGF)0
|b 23
700 1 _ |a Boesch, Sylvia
|0 P:(DE-HGF)0
|b 24
700 1 _ |a Szymanski, Sandra
|0 P:(DE-HGF)0
|b 25
700 1 _ |a Berciano, José
|0 P:(DE-HGF)0
|b 26
700 1 _ |a Infante, Jon
|0 P:(DE-HGF)0
|b 27
700 1 _ |a Buerk, Katrin
|0 P:(DE-HGF)0
|b 28
700 1 _ |a Masciullo, Marcella
|0 P:(DE-HGF)0
|b 29
700 1 _ |a Di Fabio, Roberto
|0 P:(DE-HGF)0
|b 30
700 1 _ |a Depondt, Chantal
|0 P:(DE-HGF)0
|b 31
700 1 _ |a Ratka, Susanne
|0 P:(DE-HGF)0
|b 32
700 1 _ |a Stevanin, Giovanni
|0 P:(DE-HGF)0
|b 33
700 1 _ |a Klockgether, Thomas
|0 P:(DE-2719)2810314
|b 34
|u dzne
700 1 _ |a Brice, Alexis
|0 P:(DE-HGF)0
|b 35
700 1 _ |a Golmard, Jean-Louis
|0 P:(DE-HGF)0
|b 36
773 1 8 |a 10.1136/jmedgenet-2013-102200
|b : BMJ, 2014-04-29
|n 7
|p 479-486
|3 journal-article
|2 Crossref
|t Journal of Medical Genetics
|v 51
|y 2014
|x 0022-2593
773 _ _ |a 10.1136/jmedgenet-2013-102200
|g Vol. 51, no. 7, p. 479 - 486
|0 PERI:(DE-600)2009590-9
|n 7
|q 51:7<479 - 486
|p 479-486
|t Journal of medical genetics
|v 51
|y 2014
|x 0022-2593
856 7 _ |2 Pubmed Central
|u http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4078703
909 C O |o oai:pub.dzne.de:137436
|p VDB
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 8
|6 P:(DE-2719)2810795
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 34
|6 P:(DE-2719)2810314
913 1 _ |a DE-HGF
|b Forschungsbereich Gesundheit
|l Erkrankungen des Nervensystems
|1 G:(DE-HGF)POF3-340
|0 G:(DE-HGF)POF3-344
|2 G:(DE-HGF)POF3-300
|v Clinical and Health Care Research
|x 0
913 1 _ |a DE-HGF
|b Forschungsbereich Gesundheit
|l Erkrankungen des Nervensystems
|1 G:(DE-HGF)POF3-340
|0 G:(DE-HGF)POF3-345
|2 G:(DE-HGF)POF3-300
|v Population Studies and Genetics
|x 1
914 1 _ |y 2014
915 _ _ |a Allianz-Lizenz
|0 StatID:(DE-HGF)0410
|2 StatID
915 _ _ |a Nationallizenz
|0 StatID:(DE-HGF)0420
|2 StatID
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0310
|2 StatID
|b NCBI Molecular Biology Database
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0320
|2 StatID
|b PubMed Central
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b J MED GENET : 2017
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
915 _ _ |a WoS
|0 StatID:(DE-HGF)0110
|2 StatID
|b Science Citation Index
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
915 _ _ |a WoS
|0 StatID:(DE-HGF)0111
|2 StatID
|b Science Citation Index Expanded
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1110
|2 StatID
|b Current Contents - Clinical Medicine
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1030
|2 StatID
|b Current Contents - Life Sciences
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1050
|2 StatID
|b BIOSIS Previews
915 _ _ |a IF >= 5
|0 StatID:(DE-HGF)9905
|2 StatID
|b J MED GENET : 2017
920 1 _ |0 I:(DE-2719)5000005
|k AG Schöls 1
|l Clinical Neurogenetics
|x 0
920 1 _ |0 I:(DE-2719)1011101
|k Patient studies, Bonn
|l Patient studies
|x 1
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a I:(DE-2719)5000005
980 _ _ |a I:(DE-2719)1011101
980 _ _ |a UNRESTRICTED
999 C 5 |a 10.1016/S1474-4422(10)70183-6
|9 -- missing cx lookup --
|2 Crossref
|o 10.1016/S1474-4422(10)70183-6
999 C 5 |a 10.1007/s12311-008-0010-7
|9 -- missing cx lookup --
|2 Crossref
|o 10.1007/s12311-008-0010-7
999 C 5 |a 10.1002/ana.20424
|9 -- missing cx lookup --
|2 Crossref
|o 10.1002/ana.20424
999 C 5 |a 10.1002/mds.22288
|9 -- missing cx lookup --
|2 Crossref
|o 10.1002/mds.22288
999 C 5 |a 10.1038/sj.ejhg.5200403
|9 -- missing cx lookup --
|2 Crossref
|o 10.1038/sj.ejhg.5200403
999 C 5 |a 10.1111/j.1399-0004.2004.00241.x
|9 -- missing cx lookup --
|2 Crossref
|o 10.1111/j.1399-0004.2004.00241.x
999 C 5 |a 10.1002/ajmg.b.30992
|9 -- missing cx lookup --
|2 Crossref
|o 10.1002/ajmg.b.30992
999 C 5 |a 10.1136/jnnp.2007.128728
|9 -- missing cx lookup --
|2 Crossref
|o 10.1136/jnnp.2007.128728
999 C 5 |a 10.1111/j.1399-0004.2009.01358.x
|9 -- missing cx lookup --
|2 Crossref
|o 10.1111/j.1399-0004.2009.01358.x
999 C 5 |a 10.1016/S1474-4422(13)70104-2
|9 -- missing cx lookup --
|2 Crossref
|o 10.1016/S1474-4422(13)70104-2
999 C 5 |a 10.1212/01.wnl.0000219042.60538.92
|9 -- missing cx lookup --
|2 Crossref
|o 10.1212/01.wnl.0000219042.60538.92
999 C 5 |a 10.1007/978-1-4615-0117-6_3
|9 -- missing cx lookup --
|2 Crossref
|o 10.1007/978-1-4615-0117-6_3
999 C 5 |a 10.1002/ana.410390411
|9 -- missing cx lookup --
|2 Crossref
|o 10.1002/ana.410390411
999 C 5 |a 10.1073/pnas.0308679101
|9 -- missing cx lookup --
|2 Crossref
|o 10.1073/pnas.0308679101
999 C 5 |2 Crossref
|o


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21